COMPASS Pathways plc (CMPS) AI-Powered Stock Analysis
See how COMPASS Pathways plc scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
CMPS●NASDAQ
HealthcareMedical - Care Facilities
$11.62
$0.17(1.41%)
U.S. Market is Open · 10:06
Advertisement
COMPASS Pathways plc (CMPS)
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerCOMPASS Pathways plc (CMPS) Stock Overall Grade
COMPASS Pathways plc’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to COMPASS Pathways plc's overall stock rating.
Forecast
C+Score
54/100Financial Growth
CScore
40/100Fundamental Growth
CScore
41/100Key Ratios
C+Score
55/100Sector Comparison
C+Score
50/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
99/100Analyst Consensus
C+Score
50/100COMPASS Pathways plc (CMPS) AI-Powered Stock Analysis
This asset demonstrates Normal performance with an overall Forecast Score of 54/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (41/100, C) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (50/100, C+) indicate weak positioning. Compared to broader benchmarks like the S&P 500 (99/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests Low divergence in outlook.Component Analysis Explained
Understand the key factors behind each COMPASS Pathways plc stock grade, including financials, comparisons, and forecasts.